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Introduction
Familial Mediterranean Fever (FMF) is a disease charac-
terized by attacks and colchicine is the medication con-
sidered most effective in reducing the intensity and
frequency of attacks. Adherence to the medication regi-
ment is important not only to manage FMF symptoms,
but also to prevent amyloidosis.
Objectives
In this study, it is aimed to develop and assess the validity
and reliability of the adherence scale for colchicine treat-
ment in pediatric FMF patients.
Methods
This study was planned as a methodological study to
development of scale for assessment of adherence to
treatment of pediatric patients with FMF using colchicine
treatment. Pediatric patients (2-18 ages) with FMF using
colchicine at least 6 months and accepted to participate
in the study constitute the sample of the study. “Data col-
lection forms about the sociodemographic and medical
information (demographic, clinical and laboratory find-
ings) of patients”, “adherence scale for colchicine
in pediatric FMF patients” and “Morisky Medication
Adherence Scale” were used as data collection instru-
ments. If the patient was under 7 years old, his parents
filled the forms.
Results
There were 150 patients with FMF enrolled for the vali-
dation of the study. The median age of the patients was
11.11 ± 4.02 (min.2.74-max.17.99) and 48.7% of them
were male. The median of the attack frequency was
11,00 ± 10,74(min. 0-max 52) and 60.7% of the partici-
pants had irregular attacks.
For internal consistency, Cronbach’s alpha was 0,728
for “adherence scale for colchicine in pediatric FMF
patients”. Also, there was a positive and significant cor-
relation (r: 0.843, p < 0.001) between test and retest
score. As a result it is accepted that this scale can be
used for pediatric patients with FMF who use colchicine
as a “reliable scale”. As a “content validity” 13 experts’
opinion were taken. As a “surface validity” a preliminary
test was applied with 15 patients. For the “criterion
validity” the correlation between this scale and Morisky
medication adherence scale was evaluated and for the
“structure” validity, factor analyzes and Kaiser-Meyer-
Olkin tests were performed. According to the results
this scale was accepted as a “valid” to assessing of adher-
ence to treatment of pediatric patients with FMF who
use colchicine.
Conclusion
Based on these results, using this scale for the purpose
of the assessment and follow up of adherence to treat-
ment of pediatric patients with FMF who use colchicine
is recommended.
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